Didier Surdez

8.0k total citations · 1 hit paper
33 papers, 1.2k citations indexed

About

Didier Surdez is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Didier Surdez has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Didier Surdez's work include Sarcoma Diagnosis and Treatment (12 papers), CAR-T cell therapy research (6 papers) and Cancer Genomics and Diagnostics (5 papers). Didier Surdez is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), CAR-T cell therapy research (6 papers) and Cancer Genomics and Diagnostics (5 papers). Didier Surdez collaborates with scholars based in France, Switzerland and United States. Didier Surdez's co-authors include Olivier Delattre, Thomas G. P. Grünewald, Florencia Cidre‐Aranaz, Heinrich Kovar, Eleni M. Tomazou, Poul H. Sorensen, Uta Dirksen, Enrique de Álava, Franck Tirode and Emmanuel Barillot and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Didier Surdez

31 papers receiving 1.2k citations

Hit Papers

Ewing sarcoma 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ewing sarcoma
    2018 482 citations Thomas G. P. Grünewald, Florencia Cidre‐Aranaz et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Didier Surdez France 18 653 516 263 220 172 33 1.2k
Dave N.T. Aryee Austria 17 614 0.9× 483 0.9× 250 1.0× 153 0.7× 124 0.7× 31 965
Eric D. Young United States 18 376 0.6× 408 0.8× 276 1.0× 184 0.8× 99 0.6× 33 943
David Tran United States 20 528 0.8× 253 0.5× 485 1.8× 255 1.2× 58 0.3× 39 1.4k
Josep Roma Spain 20 640 1.0× 185 0.4× 151 0.6× 301 1.4× 66 0.4× 49 900
Hilary Blair United States 12 429 0.7× 249 0.5× 169 0.6× 319 1.4× 114 0.7× 17 1.2k
Jaya Goyal United States 15 438 0.7× 224 0.4× 264 1.0× 57 0.3× 200 1.2× 38 1.4k
Diederik R.H. de Bruijn Netherlands 22 794 1.2× 500 1.0× 282 1.1× 105 0.5× 157 0.9× 25 1.2k
Linda Shyue Huey Chuang Singapore 17 1.0k 1.6× 157 0.3× 347 1.3× 279 1.3× 105 0.6× 27 1.4k
H. J. Altermatt Switzerland 17 562 0.9× 222 0.4× 274 1.0× 143 0.7× 76 0.4× 38 1.2k
Yanlin Yu United States 18 913 1.4× 194 0.4× 377 1.4× 197 0.9× 118 0.7× 35 1.5k

Countries citing papers authored by Didier Surdez

Since Specialization
Citations

This map shows the geographic impact of Didier Surdez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Surdez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Surdez more than expected).

Fields of papers citing papers by Didier Surdez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Surdez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Surdez. The network helps show where Didier Surdez may publish in the future.

Co-authorship network of co-authors of Didier Surdez

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Surdez. A scholar is included among the top collaborators of Didier Surdez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Surdez. Didier Surdez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Felix, A., Mehdi Brahmi, Nathalie Gaspar, et al.. (2025). Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium. JCO Precision Oncology. 9(9). e2500377–e2500377.
2.
Sill, Martin, Rupert Öllinger, Enrique de Álava, et al.. (2025). Genomic and phenotypic stability of fusion-driven pediatric sarcoma cell lines. Nature Communications. 16(1). 380–380. 2 indexed citations
3.
Morice, Sarah, Didier Surdez, Olivier Delattre, et al.. (2024). Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer. Molecular Cancer Therapeutics. 23(6). 864–876. 1 indexed citations
4.
Wachtel, Marco, Didier Surdez, Thomas G. P. Grünewald, & Beat W. Schäfer. (2024). Functional Classification of Fusion Proteins in Sarcoma. Cancers. 16(7). 1355–1355. 3 indexed citations
5.
Porpiglia, Ermelinda, Andrea J. De Micheli, Joana G. Marques, et al.. (2023). Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Science Advances. 9(6). eade9238–eade9238. 31 indexed citations
6.
Watson, Sarah, Collette A. LaVigne, Lin Xu, et al.. (2023). VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis. Cell Reports. 42(1). 112013–112013. 9 indexed citations
7.
Tabone‐Eglinger, Séverine, Didier Surdez, Olivier Delattre, et al.. (2022). Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement. European Journal of Cancer. 179. 56–64. 7 indexed citations
8.
Solé, Anna, Sandrine Grossetête, Loélia Babin, et al.. (2021). Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells. Cancer Research. 81(19). 4994–5006. 41 indexed citations
9.
Surdez, Didier, Sakina Zaïdi, Sandrine Grossetête, et al.. (2021). STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma. Cancer Cell. 39(6). 810–826.e9. 53 indexed citations
10.
Breunis, Willemijn B., Jan J. Molenaar, Johannes H. M. Merks, et al.. (2020). Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity. Nature Communications. 11(1). 4629–4629. 22 indexed citations
11.
Gautier, Emilie‐Fleur, Didier Surdez, Yaël Zermati, et al.. (2020). The epigenetic regulator RINF (CXXC5) maintains <I>SMAD7</I> expression in human immature erythroid cells and sustains red blood cell expansion. Haematologica. 107(1). 268–283. 3 indexed citations
12.
Selfe, Joanna, Marco Wachtel, Eleanor M. O’Brien, et al.. (2019). Aurora A Kinase Inhibition Destabilizes PAX3-FOXO1 and MYCN and Synergizes with Navitoclax to Induce Rhabdomyosarcoma Cell Death. Cancer Research. 80(4). 832–842. 42 indexed citations
13.
Romero‐Pérez, Laura, Didier Surdez, Erika Brunet, Olivier Delattre, & Thomas G. P. Grünewald. (2019). STAG Mutations in Cancer. Trends in cancer. 5(8). 506–520. 32 indexed citations
14.
Grünewald, Thomas G. P., Florencia Cidre‐Aranaz, Didier Surdez, et al.. (2018). Ewing sarcoma. Nature Reviews Disease Primers. 4(1). 5–5. 482 indexed citations breakdown →
15.
Chauvin, Céline, Amaury Leruste, Arnault Tauziède‐Espariat, et al.. (2017). High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid Tumors. Cell Reports. 21(7). 1737–1745. 23 indexed citations
16.
Cidre‐Aranaz, Florencia, Thomas G. P. Grünewald, Didier Surdez, et al.. (2016). EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma. Oncogene. 36(6). 766–776. 25 indexed citations
17.
18.
Surdez, Didier, Magdalena Benetkiewicz, Virginie Perrin, et al.. (2012). Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth. Cancer Research. 72(17). 4494–4503. 44 indexed citations
19.
Pauwels, Edouard, Didier Surdez, Gautier Stoll, et al.. (2012). A Probabilistic Model for Cell Population Phenotyping Using HCS Data. PLoS ONE. 7(8). e42715–e42715. 4 indexed citations
20.
Surdez, Didier, Bernard Delyon, Gautier Stoll, et al.. (2010). Localizing potentially active post-transcriptional regulations in the Ewing's sarcoma gene regulatory network. BMC Systems Biology. 4(1). 146–146. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dave N.T. Aryee Breakdown of academic impact, for papers by Eric D. Young Breakdown of academic impact, for papers by David Tran Breakdown of academic impact, for papers by Josep Roma Breakdown of academic impact, for papers by Hilary Blair Breakdown of academic impact, for papers by Jaya Goyal Breakdown of academic impact, for papers by Diederik R.H. de Bruijn Breakdown of academic impact, for papers by Linda Shyue Huey Chuang Breakdown of academic impact, for papers by H. J. Altermatt Breakdown of academic impact, for papers by Yanlin Yu
Rankless by CCL
2026